About The Psychedelic Journal
Independent journal of psychedelic research and law.
The Psychedelic Journal tracks the state legal status of psilocybin, MDMA, and ketamine, the FDA pipeline, and clinical access, and publishes research commentary, guides, and fact-checks.
What We Publish
- Law tracker: where psychedelics stand state by state.
- Research landscape and data on trials and the FDA pipeline.
- Guides and commentary on the research and the law.
- Tools for checking legal status and clinical access.
- People profiles of researchers and public figures in the field.
Medical Review
Guides and commentary on The Psychedelic Journal are reviewed by Dr. Michael Teplitsky, our medical reviewer. Routine wording and formatting edits do not change a page's medical-review date unless the underlying analysis changes.
Sources and Corrections
Our sources and methodology page explains how we monitor public sources, dockets, literature, and news. If you spot an error, our corrections policy explains how to report it.
Contact
Reach the editors at editor@mindmedicinelaw.com.
Content on The Psychedelic Journal is for education and is not medical advice. If you need help now, see our crisis resources.